Last 12 months
Inside the activity.
13 purchase rows · 14 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 5 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 3 |
| Jun 2026 | 5 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 8 |
| Sep 2026 | 3 | 3 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 18, 2025 Filed Dec 24, 2025 02:30 UTC Amendment |
GEYGAN JAMESDirector · 10% owner
|
GrantCommon Stock | 39,682 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-331308 · ownership.xml · nonDerivative · entry 1 GEYGAN JAMES · CIK 0001734726 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,281 F1 · shares: On June 18, 2025, the Reporting Person received a grant of 39,682 restricted stock units ("RSUs") under the Issuer's 2022 Omnibus Equity Incentive Plan. The RSUs vest in three equal annual installments beginning on the first anniversary of the grant date, subject to accelerated vesting in certain circumstances. Read SEC document |
| June 10, 2025 Filed Jun 20, 2025 22:20 UTC |
Patrick Donald HuntleyChief Executive Officer
|
SaleCommon Stock | 28,172 | $1.81 | $51,101.19 |
DisclosureSEC source: 0001437749-25-020962 · rdgdoc.xml · nonDerivative · entry 1 Patrick Donald Huntley · CIK 0001735387 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300,891 Read SEC document |
| June 10, 2025 Filed Jun 12, 2026 20:20 UTC |
Patrick Donald HuntleyChief Executive Officer
|
SaleCommon Stock | 1,353 | $1.81 | $2,454.21 |
DisclosureSEC source: 0001437749-26-020485 · rdgdoc.xml · nonDerivative · entry 2 Patrick Donald Huntley · CIK 0001735387 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 314,007 F2 · kind: The shares were sold to cover tax withholding obligations. Read SEC document |
| June 10, 2025 Filed Jun 12, 2026 20:20 UTC |
Patrick Donald HuntleyChief Executive Officer
|
GrantCommon Stock | 3,191 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-26-020485 · rdgdoc.xml · nonDerivative · entry 1 Patrick Donald Huntley · CIK 0001735387 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 315,360 F1 · shares: On October 3, 2022, the Issuer approved an award of 25,528 performance stock units ("PSUs") to the Reporting Person under the Fluent, Inc. 2022 Omnibus Equity Incentive Plan, subject to the achievement of certain financial targets. Targets were measured over a three-year period resulting in the issuance of 3,191 PSUs, with the remainder of the PSUs being forfeited. Read SEC document |
| May 19, 2025 Filed May 20, 2025 01:53 UTC |
GEYGAN JAMESDirector · 10% owner
|
OtherCommon Stock | 8,104 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-074837 · ownership.xml · nonDerivative · entry 1 GEYGAN JAMES · CIK 0001734726 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Global Value Investment Corporation Disclosed balance after: 3,049,085 F1 · price: As of May 19, 2025, certain separately managed accounts terminated their relationship with, and are no longer advised by, Global Value Investment Corporation. The positions held in such accounts are therefore no longer included herein. F2 · ownership.nature: These securities are held in one or more accounts managed indirectly by Global Value Investment Corporation or its subsidiary or its affiliated persons/entities (collectively, "GVIC"). The reporting person is the CEO and President of GVIC. These securities may be deemed to be beneficially owned by GVIC because it serves as the investment manager and/or investment advisor to separately managed accounts, investment partnerships, and/or individuals, and by the reporting person because he exercises significant managerial control over GVIC. The reporting person disclaims beneficial ownership in the securities except to the extent of his pecuniary interest, if any, and this report shall not be deemed to be an admission that the reporting person is the beneficial owner of such securities for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| May 19, 2025 Filed May 20, 2025 15:16 UTC |
GLOBAL VALUE INVESTMENT CORP.10% owner
GEYGAN JEFFREY RICHARTDirector of GVIC
GEYGAN JAMESDirector · 10% owner
Wilke StacyOfficer of GVIC
Geygan KathleenDirector of GVIC
Rice Shawn GDirector of GVIC
|
OtherCommon Stock | 8,104 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-074969 · ownership.xml · nonDerivative · entry 1 GLOBAL VALUE INVESTMENT CORP. · CIK 0001569866 · 10% owner GEYGAN JEFFREY RICHART · CIK 0001733547 · Director of GVIC GEYGAN JAMES · CIK 0001734726 · Director · 10% owner Wilke Stacy · CIK 0001865363 · Officer of GVIC Geygan Kathleen · CIK 0001865425 · Director of GVIC Rice Shawn G · CIK 0002007274 · Director of GVIC Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Global Value Investment Corporation Disclosed balance after: 3,058,299 F1 · price: As of May 19, 2025, certain separately managed accounts terminated their relationship with, and are no longer advised by, Global Value Investment Corporation. The positions held in such accounts are therefore no longer included herein. F2 · ownership.nature: In addition to Global Value Investment Corporation, a Delaware corporation, this Form 4 is being filed jointly by Jeffrey R. Geygan, a citizen of the United States of America, James P. Geygan, a citizen of the United States of America, Stacy A. Wilke, a citizen of the United States of America, Kathleen M. Geygan, a citizen of the United States of America, and Shawn G. Rice, a citizen of the United States of America, each of whom has the same business address as Global Value Investment Corporation. Global Value Investment Corporation beneficially owns the shares of common stock, par value $0.0005 per share ("Common Stock"), of Fluent, Inc. reported on this Form 4. F3 · ownership.nature: In accordance with Instruction 4(b)(iv), the entire amount of Common Stock held by Global Value Investment Corporation is reported herein. Common Stock reported as indirectly owned by Global Value Investment Corporation includes shares owned by Jeffrey R. Geygan, James P. Geygan, Stacy A. Wilke, Kathleen M. Geygan, and Shawn G. Rice. Read SEC document |
| May 19, 2025 Filed May 21, 2025 20:15 UTC |
FROST PHILLIP MD ET AL10% owner
Frost Gamma Investments Trust10% owner
|
Disposition to issuerPre-Funded Warrants · Derivative | 909,297 | $2.20 Strike: $0.00 | $1,999,998.75 |
DisclosureSEC source: 0001104659-25-051611 · tm2515842-1_4seq1.xml · derivative · entry 6 FROST PHILLIP MD ET AL · CIK 0000898860 · 10% owner Frost Gamma Investments Trust · CIK 0001380896 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Frost Gamma Investments Trust Disclosed balance after: 0 Underlying: Common Stock · 909,297 shares Expires not disclosed F3 · derivative.exercise_date: The Pre-Funded Warrants were immediately exercisable when issued and were exercised on May 19, 2025. F2 · derivative.expiration_date: The Pre-Funded Warrants expire when exercised in full. F1 · ownership.nature: These securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole stockholder of Frost-Nevada Corporation. The reporting persons disclaim beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that any reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| May 19, 2025 Filed May 21, 2025 20:15 UTC |
FROST PHILLIP MD ET AL10% owner
Frost Gamma Investments Trust10% owner
|
GrantWarrants · Derivative | 909,297 | $0.00 Strike: $2.20 | $0.00 |
DisclosureSEC source: 0001104659-25-051611 · tm2515842-1_4seq1.xml · derivative · entry 5 FROST PHILLIP MD ET AL · CIK 0000898860 · 10% owner Frost Gamma Investments Trust · CIK 0001380896 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Frost Gamma Investments Trust Disclosed balance after: 909,297 Underlying: Common Stock · 909,297 shares Expires not disclosed F4 · derivative.expiration_date: The Warrants will expire three years from the date of issuance. F1 · ownership.nature: These securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole stockholder of Frost-Nevada Corporation. The reporting persons disclaim beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that any reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| May 19, 2025 Filed May 21, 2025 20:15 UTC |
FROST PHILLIP MD ET AL10% owner
Frost Gamma Investments Trust10% owner
|
GrantPre-Funded Warrants · Derivative | 909,297 | $2.20 Strike: $0.00 | $1,999,998.75 |
DisclosureSEC source: 0001104659-25-051611 · tm2515842-1_4seq1.xml · derivative · entry 4 FROST PHILLIP MD ET AL · CIK 0000898860 · 10% owner Frost Gamma Investments Trust · CIK 0001380896 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Frost Gamma Investments Trust Disclosed balance after: 909,297 Underlying: Common Stock · 909,297 shares Expires not disclosed F3 · derivative.exercise_date: The Pre-Funded Warrants were immediately exercisable when issued and were exercised on May 19, 2025. F2 · derivative.expiration_date: The Pre-Funded Warrants expire when exercised in full. F1 · ownership.nature: These securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole stockholder of Frost-Nevada Corporation. The reporting persons disclaim beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that any reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| May 19, 2025 Filed May 21, 2025 20:15 UTC |
FROST PHILLIP MD ET AL10% owner
Frost Gamma Investments Trust10% owner
|
Tax withholdingCommon Stock | 212 | $2.13 | $451.56 |
DisclosureSEC source: 0001104659-25-051611 · tm2515842-1_4seq1.xml · nonDerivative · entry 2 FROST PHILLIP MD ET AL · CIK 0000898860 · 10% owner Frost Gamma Investments Trust · CIK 0001380896 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Frost Gamma Investments Trust Disclosed balance after: 5,747,010 F1 · ownership.nature: These securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole stockholder of Frost-Nevada Corporation. The reporting persons disclaim beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that any reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| May 19, 2025 Filed May 21, 2025 20:15 UTC |
FROST PHILLIP MD ET AL10% owner
Frost Gamma Investments Trust10% owner
|
OtherCommon Stock | 909,297 | $0.00 | $454.65 |
DisclosureSEC source: 0001104659-25-051611 · tm2515842-1_4seq1.xml · nonDerivative · entry 1 FROST PHILLIP MD ET AL · CIK 0000898860 · 10% owner Frost Gamma Investments Trust · CIK 0001380896 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Frost Gamma Investments Trust Disclosed balance after: 5,747,222 F1 · ownership.nature: These securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole stockholder of Frost-Nevada Corporation. The reporting persons disclaim beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that any reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| May 15, 2025 Filed May 20, 2025 01:53 UTC |
GEYGAN JAMESDirector · 10% owner
|
GrantWarrants · Derivative | 67,059 | $0.00 Strike: $2.20 | $0.00 |
DisclosureSEC source: 0000950170-25-074837 · ownership.xml · derivative · entry 6 GEYGAN JAMES · CIK 0001734726 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Global Value Investment Corporation Disclosed balance after: 67,059 Underlying: Common Stock · 67,059 shares Expires not disclosed F5 · derivative.exercise_date: The Warrants will be exercisable after stockholder approval of the offering of the Warrants. F6 · derivative.expiration_date: The Warrants will expire three years from the date of issuance. F2 · ownership.nature: These securities are held in one or more accounts managed indirectly by Global Value Investment Corporation or its subsidiary or its affiliated persons/entities (collectively, "GVIC"). The reporting person is the CEO and President of GVIC. These securities may be deemed to be beneficially owned by GVIC because it serves as the investment manager and/or investment advisor to separately managed accounts, investment partnerships, and/or individuals, and by the reporting person because he exercises significant managerial control over GVIC. The reporting person disclaims beneficial ownership in the securities except to the extent of his pecuniary interest, if any, and this report shall not be deemed to be an admission that the reporting person is the beneficial owner of such securities for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| May 15, 2025 Filed May 20, 2025 01:53 UTC |
GEYGAN JAMESDirector · 10% owner
|
GrantPre-Funded Warrants · Derivative | 67,059 | $2.20 Strike: $0.00 | $147,496.27 |
DisclosureSEC source: 0000950170-25-074837 · ownership.xml · derivative · entry 5 GEYGAN JAMES · CIK 0001734726 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Global Value Investment Corporation Disclosed balance after: 67,059 Underlying: Common Stock · 67,059 shares Expires not disclosed F3 · derivative.exercise_date: The Pre-Funded Warrants will be exercisable after stockholder approval of the offering of the Pre-Funded Warrants. F4 · derivative.expiration_date: The Pre-Funded Warrants will terminate when exercised in full. F2 · ownership.nature: These securities are held in one or more accounts managed indirectly by Global Value Investment Corporation or its subsidiary or its affiliated persons/entities (collectively, "GVIC"). The reporting person is the CEO and President of GVIC. These securities may be deemed to be beneficially owned by GVIC because it serves as the investment manager and/or investment advisor to separately managed accounts, investment partnerships, and/or individuals, and by the reporting person because he exercises significant managerial control over GVIC. The reporting person disclaims beneficial ownership in the securities except to the extent of his pecuniary interest, if any, and this report shall not be deemed to be an admission that the reporting person is the beneficial owner of such securities for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| May 15, 2025 Filed May 20, 2025 01:53 UTC |
GEYGAN JAMESDirector · 10% owner
|
GrantWarrants · Derivative | 11,366 | $0.00 Strike: $2.20 | $0.00 |
DisclosureSEC source: 0000950170-25-074837 · ownership.xml · derivative · entry 4 GEYGAN JAMES · CIK 0001734726 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,366 Underlying: Common Stock · 11,366 shares Expires not disclosed F5 · derivative.exercise_date: The Warrants will be exercisable after stockholder approval of the offering of the Warrants. F6 · derivative.expiration_date: The Warrants will expire three years from the date of issuance. Read SEC document |
| May 15, 2025 Filed May 20, 2025 01:53 UTC |
GEYGAN JAMESDirector · 10% owner
|
GrantPre-Funded Warrants · Derivative | 11,366 | $2.20 Strike: $0.00 | $24,999.52 |
DisclosureSEC source: 0000950170-25-074837 · ownership.xml · derivative · entry 3 GEYGAN JAMES · CIK 0001734726 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,366 Underlying: Common Stock · 11,366 shares Expires not disclosed F3 · derivative.exercise_date: The Pre-Funded Warrants will be exercisable after stockholder approval of the offering of the Pre-Funded Warrants. F4 · derivative.expiration_date: The Pre-Funded Warrants will terminate when exercised in full. Read SEC document |
| May 15, 2025 Filed May 20, 2025 00:32 UTC |
Patrick Donald HuntleyChief Executive Officer
|
GrantWarrant · Derivative | 12,502 | $0.00 Strike: $2.20 | $0.00 |
DisclosureSEC source: 0001437749-25-017698 · rdgdoc.xml · derivative · entry 2 Patrick Donald Huntley · CIK 0001735387 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,502 Underlying: Common Stock · 12,502 shares Expires not disclosed F3 · derivative.exercise_date: The Warrants will be immediately exercisable after stockholder approval of the offering of the Warrants. F4 · derivative.expiration_date: The Warrants will expire three years from the date of issuance. Read SEC document |
| May 15, 2025 Filed May 20, 2025 00:32 UTC |
Patrick Donald HuntleyChief Executive Officer
|
GrantPre-Funded Warrant · Derivative | 12,502 | $0.00 Strike: $0.00 | $6.25 |
DisclosureSEC source: 0001437749-25-017698 · rdgdoc.xml · derivative · entry 1 Patrick Donald Huntley · CIK 0001735387 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,502 Underlying: Common Stock · 12,502 shares Expires not disclosed F1 · derivative.exercise_date: The Pre-Funded Warrants will be immediately exercisable after stockholder approval of the offering of the Issuer's Pre-Funded Warrants. F2 · derivative.expiration_date: The Pre-Funded Warrants will terminate when exercised in full. Read SEC document |
| May 15, 2025 Filed May 20, 2025 00:28 UTC |
Conlin MatthewDirector · Chief Customer Officer · 10% owner
|
GrantWarrant · Derivative | 454,648 | $0.00 Strike: $2.20 | $0.00 |
DisclosureSEC source: 0001437749-25-017696 · rdgdoc.xml · derivative · entry 2 Conlin Matthew · CIK 0001660879 · Director · Chief Customer Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 454,648 Underlying: Common Stock · 454,648 shares Expires not disclosed F3 · derivative.exercise_date: The Warrants will be immediately exercisable after stockholder approval of the offering of the Pre-Funded Warrants. F4 · derivative.expiration_date: The Warrants will expire three years from the date of issuance. Read SEC document |
| May 15, 2025 Filed May 20, 2025 00:28 UTC |
Conlin MatthewDirector · Chief Customer Officer · 10% owner
|
GrantPre-Funded Warrant · Derivative | 454,648 | $0.00 Strike: $0.00 | $227.32 |
DisclosureSEC source: 0001437749-25-017696 · rdgdoc.xml · derivative · entry 1 Conlin Matthew · CIK 0001660879 · Director · Chief Customer Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 454,648 Underlying: Common Stock · 454,648 shares Expires not disclosed F1 · derivative.exercise_date: The Pre-Funded Warrants will be immediately exercisable after stockholder approval of the offering of the Issuer's Pre-Funded Warrants. F2 · derivative.expiration_date: The Pre-Funded Warrants will terminate when exercised in full. Read SEC document |
| May 15, 2025 Filed May 20, 2025 00:27 UTC |
Schulke RyanDirector · Chief Strategy Officer · 10% owner
|
GrantWarrants · Derivative | 227,324 | $0.00 Strike: $2.20 | $0.00 |
DisclosureSEC source: 0001437749-25-017694 · rdgdoc.xml · derivative · entry 2 Schulke Ryan · CIK 0001660850 · Director · Chief Strategy Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 227,324 Underlying: Common Stock · 227,324 shares Expires not disclosed F3 · derivative.exercise_date: The Warrants will be exercisable after stockholder approval of the offering of the Warrants. F4 · derivative.expiration_date: The Warrants will expire three years from the date of issuance. Read SEC document |
| May 15, 2025 Filed May 20, 2025 00:27 UTC |
Schulke RyanDirector · Chief Strategy Officer · 10% owner
|
GrantPre-Funded Warrants · Derivative | 227,324 | $2.20 Strike: $0.00 | $499,999.14 |
DisclosureSEC source: 0001437749-25-017694 · rdgdoc.xml · derivative · entry 1 Schulke Ryan · CIK 0001660850 · Director · Chief Strategy Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 227,324 Underlying: Common Stock · 227,324 shares Expires not disclosed F1 · derivative.exercise_date: The Pre-Funded Warrants will be exercisable after stockholder approval of the offering of the Pre-Funded Warrants. F2 · derivative.expiration_date: The Pre-Funded Warrants will terminate when exercised in full. Read SEC document |
| May 15, 2025 Filed May 20, 2025 15:16 UTC |
GLOBAL VALUE INVESTMENT CORP.10% owner
GEYGAN JEFFREY RICHARTDirector of GVIC
GEYGAN JAMESDirector · 10% owner
Wilke StacyOfficer of GVIC
Geygan KathleenDirector of GVIC
Rice Shawn GDirector of GVIC
|
GrantWarrants · Derivative | 78,425 | $0.00 Strike: $2.20 | $0.00 |
DisclosureSEC source: 0000950170-25-074969 · ownership.xml · derivative · entry 4 GLOBAL VALUE INVESTMENT CORP. · CIK 0001569866 · 10% owner GEYGAN JEFFREY RICHART · CIK 0001733547 · Director of GVIC GEYGAN JAMES · CIK 0001734726 · Director · 10% owner Wilke Stacy · CIK 0001865363 · Officer of GVIC Geygan Kathleen · CIK 0001865425 · Director of GVIC Rice Shawn G · CIK 0002007274 · Director of GVIC Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Global Value Investment Corporation Disclosed balance after: 78,425 Underlying: Common Stock · 78,425 shares Expires not disclosed F7 · derivative.exercise_date: The Warrants will be exercisable after stockholder approval of the offering of the Warrants. F8 · derivative.expiration_date: The Warrants will expire three years from the date of issuance. F6 · ownership.nature: These securities are held in one or more accounts managed indirectly by Global Value Investment Corporation or its subsidiary or its affiliated persons/entities (collectively, "GVIC"). GVIC may be deemed to have beneficial ownership of these securities because it serves as the investment manager and/or investment advisor to separately managed accounts, investment partnerships, and/or individuals. The reporting person disclaims beneficial ownership in the securities except to the extent of his pecuniary interest, if any, and this report shall not be deemed to be an admission that the reporting person is the beneficial owner of such securities for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| May 15, 2025 Filed May 20, 2025 15:16 UTC |
GLOBAL VALUE INVESTMENT CORP.10% owner
GEYGAN JEFFREY RICHARTDirector of GVIC
GEYGAN JAMESDirector · 10% owner
Wilke StacyOfficer of GVIC
Geygan KathleenDirector of GVIC
Rice Shawn GDirector of GVIC
|
GrantPre-Funded Warrants · Derivative | 78,425 | $2.20 Strike: $0.00 | $172,495.79 |
DisclosureSEC source: 0000950170-25-074969 · ownership.xml · derivative · entry 3 GLOBAL VALUE INVESTMENT CORP. · CIK 0001569866 · 10% owner GEYGAN JEFFREY RICHART · CIK 0001733547 · Director of GVIC GEYGAN JAMES · CIK 0001734726 · Director · 10% owner Wilke Stacy · CIK 0001865363 · Officer of GVIC Geygan Kathleen · CIK 0001865425 · Director of GVIC Rice Shawn G · CIK 0002007274 · Director of GVIC Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Global Value Investment Corporation Disclosed balance after: 78,425 Underlying: Common Stock · 78,425 shares Expires not disclosed F4 · derivative.exercise_date: The Pre-Funded Warrants will be exercisable after stockholder approval of the offering of the Pre-Funded Warrants. F5 · derivative.expiration_date: The Pre-Funded Warrants will terminate when exercised in full. F6 · ownership.nature: These securities are held in one or more accounts managed indirectly by Global Value Investment Corporation or its subsidiary or its affiliated persons/entities (collectively, "GVIC"). GVIC may be deemed to have beneficial ownership of these securities because it serves as the investment manager and/or investment advisor to separately managed accounts, investment partnerships, and/or individuals. The reporting person disclaims beneficial ownership in the securities except to the extent of his pecuniary interest, if any, and this report shall not be deemed to be an admission that the reporting person is the beneficial owner of such securities for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| March 20, 2025 Filed Mar 21, 2025 23:33 UTC |
FROST PHILLIP MD ET AL10% owner
Frost Gamma Investments Trust10% owner
|
Exercise / conversionPre-Funded Warrants · Derivative | 459,981 | $2.17 Strike: $0.00 | $999,998.69 |
DisclosureSEC source: 0001437749-25-008804 · rdgdoc.xml · derivative · entry 4 FROST PHILLIP MD ET AL · CIK 0000898860 · 10% owner Frost Gamma Investments Trust · CIK 0001380896 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Frost Gamma Investments Trust Disclosed balance after: 459,981 Underlying: Common Stock · 459,981 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The Pre-Funded Warrants were immediately exercisable when issued. The Pre-Funded Warrants were exercised on March 20, 2025. F2 · derivative.expiration_date: The Pre-Funded Warrants terminate when exercised in full. F1 · ownership.nature: These securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole stockholder of Frost-Nevada Corporation. The reporting persons disclaim beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that any reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| March 20, 2025 Filed Mar 21, 2025 23:33 UTC |
FROST PHILLIP MD ET AL10% owner
Frost Gamma Investments Trust10% owner
|
Tax withholdingCommon Stock | 112 | $2.04 | $228.48 |
DisclosureSEC source: 0001437749-25-008804 · rdgdoc.xml · nonDerivative · entry 2 FROST PHILLIP MD ET AL · CIK 0000898860 · 10% owner Frost Gamma Investments Trust · CIK 0001380896 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Frost Gamma Investments Trust Disclosed balance after: 4,837,925 F1 · ownership.nature: These securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole stockholder of Frost-Nevada Corporation. The reporting persons disclaim beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that any reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| March 20, 2025 Filed Mar 21, 2025 23:33 UTC |
FROST PHILLIP MD ET AL10% owner
Frost Gamma Investments Trust10% owner
|
Exercise / conversionCommon Stock | 459,981 | $0.00 | $229.99 |
DisclosureSEC source: 0001437749-25-008804 · rdgdoc.xml · nonDerivative · entry 1 FROST PHILLIP MD ET AL · CIK 0000898860 · 10% owner Frost Gamma Investments Trust · CIK 0001380896 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Frost Gamma Investments Trust Disclosed balance after: 4,838,037 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: These securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole stockholder of Frost-Nevada Corporation. The reporting persons disclaim beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that any reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| March 20, 2025 Filed Mar 27, 2025 16:05 UTC Amendment |
FROST PHILLIP MD ET AL10% owner
Frost Gamma Investments Trust10% owner
|
Exercise / conversionPre-Funded Warrants · Derivative | 459,981 | $2.17 Strike: $0.00 | $999,998.69 |
DisclosureSEC source: 0001437749-25-009541 · rdgdoc.xml · derivative · entry 5 FROST PHILLIP MD ET AL · CIK 0000898860 · 10% owner Frost Gamma Investments Trust · CIK 0001380896 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Frost Gamma Investments Trust Disclosed balance after: 459,981 Underlying: Common Stock · 459,981 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The Pre-Funded Warrants were immediately exercisable when issued. The Pre-Funded Warrants were exercised on March 20, 2025. F2 · derivative.expiration_date: The Pre-Funded Warrants terminate when exercised in full. F1 · ownership.nature: These securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole stockholder of Frost-Nevada Corporation. The reporting persons disclaim beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that any reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| March 20, 2025 Filed Mar 27, 2025 16:05 UTC Amendment |
FROST PHILLIP MD ET AL10% owner
Frost Gamma Investments Trust10% owner
|
Tax withholdingCommon Stock | 112 | $2.04 | $228.48 |
DisclosureSEC source: 0001437749-25-009541 · rdgdoc.xml · nonDerivative · entry 2 FROST PHILLIP MD ET AL · CIK 0000898860 · 10% owner Frost Gamma Investments Trust · CIK 0001380896 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Frost Gamma Investments Trust Disclosed balance after: 4,837,925 F1 · ownership.nature: These securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole stockholder of Frost-Nevada Corporation. The reporting persons disclaim beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that any reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| March 20, 2025 Filed Mar 27, 2025 16:05 UTC Amendment |
FROST PHILLIP MD ET AL10% owner
Frost Gamma Investments Trust10% owner
|
Exercise / conversionCommon Stock | 459,981 | $0.00 | $229.99 |
DisclosureSEC source: 0001437749-25-009541 · rdgdoc.xml · nonDerivative · entry 1 FROST PHILLIP MD ET AL · CIK 0000898860 · 10% owner Frost Gamma Investments Trust · CIK 0001380896 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Frost Gamma Investments Trust Disclosed balance after: 4,838,037 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: These securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole stockholder of Frost-Nevada Corporation. The reporting persons disclaim beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that any reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| March 19, 2025 Filed Mar 21, 2025 23:33 UTC |
FROST PHILLIP MD ET AL10% owner
Frost Gamma Investments Trust10% owner
|
GrantPre-Funded Warrants · Derivative | 459,981 | $2.17 Strike: $0.00 | $999,998.69 |
DisclosureSEC source: 0001437749-25-008804 · rdgdoc.xml · derivative · entry 3 FROST PHILLIP MD ET AL · CIK 0000898860 · 10% owner Frost Gamma Investments Trust · CIK 0001380896 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Frost Gamma Investments Trust Disclosed balance after: 459,981 Underlying: Common Stock · 459,981 shares Expires not disclosed F2 · derivative.expiration_date: The Pre-Funded Warrants terminate when exercised in full. F1 · ownership.nature: These securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole stockholder of Frost-Nevada Corporation. The reporting persons disclaim beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that any reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| March 19, 2025 Filed Mar 21, 2025 22:45 UTC |
Schulke RyanDirector · Chief Strategy Officer · 10% owner
|
GrantPre-Funded Warrants · Derivative | 229,990 | $2.15 Strike: $0.00 | $493,788.53 |
DisclosureSEC source: 0001437749-25-008797 · rdgdoc.xml · derivative · entry 2 Schulke Ryan · CIK 0001660850 · Director · Chief Strategy Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · Schulke Inn Family Foundation Disclosed balance after: 229,990 Underlying: Common Stock · 229,990 shares Expires not disclosed F1 · derivative.exercise_date: The Pre-Funded Warrants will be exercisable after stockholder approval of the offering of the Pre-Funded Warrants. F2 · derivative.expiration_date: The Pre-Funded Warrants will terminate when exercised in full. F3 · ownership.nature: The Reporting Person is the Co-Trustee of the Schulke Inn Family Foundation Trust and in such capacity has the shared right to vote and dispose of the shares. Read SEC document |
| March 19, 2025 Filed Mar 21, 2025 22:45 UTC |
Schulke RyanDirector · Chief Strategy Officer · 10% owner
|
GrantPre-Funded Warrants · Derivative | 551,977 | $2.15 Strike: $0.00 | $1,185,094.62 |
DisclosureSEC source: 0001437749-25-008797 · rdgdoc.xml · derivative · entry 1 Schulke Ryan · CIK 0001660850 · Director · Chief Strategy Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 551,977 Underlying: Common Stock · 551,977 shares Expires not disclosed F1 · derivative.exercise_date: The Pre-Funded Warrants will be exercisable after stockholder approval of the offering of the Pre-Funded Warrants. F2 · derivative.expiration_date: The Pre-Funded Warrants will terminate when exercised in full. Read SEC document |
| March 19, 2025 Filed Mar 21, 2025 22:40 UTC |
Conlin MatthewDirector · Chief Customer Officer · 10% owner
|
GrantPre-Funded Warrant · Derivative | 689,972 | $2.15 Strike: $0.00 | $1,481,369.88 |
DisclosureSEC source: 0001437749-25-008795 · rdgdoc.xml · derivative · entry 2 Conlin Matthew · CIK 0001660879 · Director · Chief Customer Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 689,972 Underlying: Common Stock · 689,972 shares Expires not disclosed F1 · derivative.exercise_date: The Pre-Funded will be immediately exercisable after stockholder approval of the offering of the Issuer's Pre-Funded Warrants. F2 · derivative.expiration_date: The Pre-Funded Warrants will terminate when exercised in full. Read SEC document |
| March 19, 2025 Filed Mar 21, 2025 22:40 UTC |
Conlin MatthewDirector · Chief Customer Officer · 10% owner
|
GrantPre-Funded Warrant · Derivative | 229,990 | $2.15 Strike: $0.00 | $493,788.53 |
DisclosureSEC source: 0001437749-25-008795 · rdgdoc.xml · derivative · entry 1 Conlin Matthew · CIK 0001660879 · Director · Chief Customer Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · Conlin Family Trust Disclosed balance after: 229,990 Underlying: Common Stock · 229,990 shares Expires not disclosed F1 · derivative.exercise_date: The Pre-Funded will be immediately exercisable after stockholder approval of the offering of the Issuer's Pre-Funded Warrants. F2 · derivative.expiration_date: The Pre-Funded Warrants will terminate when exercised in full. F3 · ownership.nature: The Reporting Person is the co-trustee of the Conlin Family Trust and in such capacity has the shared right to vote and dispose of the securities held by such trust. Read SEC document |
| March 19, 2025 Filed Mar 21, 2025 22:35 UTC |
Patrick Donald HuntleyChief Executive Officer
|
GrantPre-Funded Warrant · Derivative | 9,199 | $2.17 Strike: $0.00 | $19,998.63 |
DisclosureSEC source: 0001437749-25-008793 · rdgdoc.xml · derivative · entry 1 Patrick Donald Huntley · CIK 0001735387 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,199 Underlying: Common Stock · 9,199 shares Expires not disclosed F1 · derivative.exercise_date: The Pre-Funded will be immediately exercisable after stockholder approval of the offering of the Issuer's Pre-Funded Warrants. F2 · derivative.expiration_date: The Pre-Funded Warrants will terminate when exercised in full. Read SEC document |
| March 19, 2025 Filed Mar 27, 2025 16:05 UTC Amendment |
FROST PHILLIP MD ET AL10% owner
Frost Gamma Investments Trust10% owner
|
GrantPre-Funded Warrants · Derivative | 459,981 | $2.17 Strike: $0.00 | $999,998.69 |
DisclosureSEC source: 0001437749-25-009541 · rdgdoc.xml · derivative · entry 4 FROST PHILLIP MD ET AL · CIK 0000898860 · 10% owner Frost Gamma Investments Trust · CIK 0001380896 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Frost Gamma Investments Trust Disclosed balance after: 459,981 Underlying: Common Stock · 459,981 shares Expires not disclosed F2 · derivative.expiration_date: The Pre-Funded Warrants terminate when exercised in full. F1 · ownership.nature: These securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole stockholder of Frost-Nevada Corporation. The reporting persons disclaim beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that any reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| January 17, 2025 Filed Jan 23, 2025 02:50 UTC |
GLOBAL VALUE INVESTMENT CORP.10% owner
GEYGAN JEFFREY RICHARTDirector of GVIC
GEYGAN JAMESDirector and Officer of GVIC
Wilke StacyOfficer of GVIC
Geygan KathleenDirector of GVIC
Rice Shawn GDirector of GVIC
|
OtherCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-008024 · ownership.xml · nonDerivative · entry 1 GLOBAL VALUE INVESTMENT CORP. · CIK 0001569866 · 10% owner GEYGAN JEFFREY RICHART · CIK 0001733547 · Director of GVIC GEYGAN JAMES · CIK 0001734726 · Director and Officer of GVIC Wilke Stacy · CIK 0001865363 · Officer of GVIC Geygan Kathleen · CIK 0001865425 · Director of GVIC Rice Shawn G · CIK 0002007274 · Director of GVIC Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes. Disclosed balance after: 3,066,403 F1 · kind: Represents restricted stock units ("RSUs") granted to Mr. James Geygan on January 17, 2025, in connection with his appointment to the Board of Directors of Fluent, Inc. Such RSUs will vest in three equal annual installments beginning on the first anniversary of the grant date, subject to accelerated vesting in certain circumstances. F2 · ownership.nature: In addition to Global Value Investment Corp, a Delaware corporation ("GVIC"), this Form 4 is being filed jointly by Jeffrey R. Geygan, a citizen of the United States of America, James P. Geygan, a citizen of the United States of America, Stacy A. Wilke, a citizen of the United States of America, Kathleen M. Geygan, a citizen of the United States of America, and Shawn G. Rice, a citizen of the United States of America, each of whom has the same business address as GVIC. GVIC beneficially owns the shares of common stock, par value $0.0005 per share ("Common Stock"), of Fluent, Inc. reported on this Form 4. F3 · ownership.nature: In accordance with Instruction 4(b)(iv), the entire amount of Common Stock held by GVIC is reported herein. Common Stock reported as indirectly owned by GVIC includes shares owned by Jeffrey R. Geygan, James P. Geygan, Stacy A. Wilke, Kathleen M. Geygan, and Shawn G. Rice. Read SEC document |
| December 09, 2024 Filed Dec 11, 2024 19:58 UTC |
FROST PHILLIP MD ET AL10% owner
Frost Gamma Investments Trust10% owner
|
OtherPre-Funded Warrant · Derivative | 647,892 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-037223 · rdgdoc.xml · derivative · entry 3 FROST PHILLIP MD ET AL · CIK 0000898860 · 10% owner Frost Gamma Investments Trust · CIK 0001380896 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Frost Gamma Investments Trust Disclosed balance after: 0 Underlying: Common Stock · 647,892 shares Expires not disclosed F2 · derivative.exercise_date: The Pre-Funded Warrants were immediately exercisable when issued. The Pre-Funded Warrants were exercised on December 9, 2024. F3 · derivative.expiration_date: The Pre-Funded Warrants will terminate when exercised in full. F2 · derivative.underlying_shares: The Pre-Funded Warrants were immediately exercisable when issued. The Pre-Funded Warrants were exercised on December 9, 2024. F1 · ownership.nature: These securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole stockholder of Frost-Nevada Corporation. The reporting persons disclaim beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that any reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| December 09, 2024 Filed Dec 11, 2024 19:58 UTC |
FROST PHILLIP MD ET AL10% owner
Frost Gamma Investments Trust10% owner
|
OtherCommon Stock | 647,892 | $0.00 | $323.95 |
DisclosureSEC source: 0001437749-24-037223 · rdgdoc.xml · nonDerivative · entry 1 FROST PHILLIP MD ET AL · CIK 0000898860 · 10% owner Frost Gamma Investments Trust · CIK 0001380896 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Frost Gamma Investments Trust Disclosed balance after: 4,378,056 F1 · ownership.nature: These securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole stockholder of Frost-Nevada Corporation. The reporting persons disclaim beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that any reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| December 05, 2024 Filed Dec 6, 2024 21:30 UTC |
GLOBAL VALUE INVESTMENT CORP.10% owner
GEYGAN JAMESDirector and Officer of GVIC
GEYGAN JEFFREY RICHARTDirector of GVIC
Wilke StacyOfficer of GVIC
Geygan KathleenDirector of GVIC
Rice Shawn GDirector of GVIC
|
PurchaseCommon Stock | 14,337 | $2.69 | $38,553.63 |
DisclosureSEC source: 0000950170-24-134141 · ownership.xml · nonDerivative · entry 3 GLOBAL VALUE INVESTMENT CORP. · CIK 0001569866 · 10% owner GEYGAN JAMES · CIK 0001734726 · Director and Officer of GVIC GEYGAN JEFFREY RICHART · CIK 0001733547 · Director of GVIC Wilke Stacy · CIK 0001865363 · Officer of GVIC Geygan Kathleen · CIK 0001865425 · Director of GVIC Rice Shawn G · CIK 0002007274 · Director of GVIC Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes. Disclosed balance after: 3,056,403 F4 · price: The reported price represents a weighted average purchase price. The Reporting Person undertakes to provide to the staff, the issuer, or a security holder full information regarding the number of shares purchased at each separate price. F2 · ownership.nature: In addition to Global Value Investment Corp, a Delaware corporation ("GVIC"), this Form 4 is being filed jointly by Jeffrey R. Geygan, a citizen of the United States of America, James P. Geygan, a citizen of the United States of America, Stacy A. Wilke, a citizen of the United States of America, Kathleen M. Geygan, a citizen of the United States of America, and Shawn G. Rice, a citizen of the United States of America, each of whom has the same business address as GVIC. GVIC beneficially owns the shares of common stock, par value $0.0005 per share ("Common Stock"), of Fluent, Inc. reported on this Form 4. F3 · ownership.nature: In accordance with Instruction 4(b)(iv), the entire amount of Common Stock held by GVIC is reported herein. Common Stock reported as indirectly owned by GVIC includes shares owned by Jeffrey R. Geygan, James P. Geygan, Stacy A. Wilke, Kathleen M. Geygan, and Shawn G. Rice. Read SEC document |
| December 04, 2024 Filed Dec 6, 2024 21:30 UTC |
GLOBAL VALUE INVESTMENT CORP.10% owner
GEYGAN JAMESDirector and Officer of GVIC
GEYGAN JEFFREY RICHARTDirector of GVIC
Wilke StacyOfficer of GVIC
Geygan KathleenDirector of GVIC
Rice Shawn GDirector of GVIC
|
PurchaseCommon Stock | 5,045 | $2.74 | $13,826.33 |
DisclosureSEC source: 0000950170-24-134141 · ownership.xml · nonDerivative · entry 2 GLOBAL VALUE INVESTMENT CORP. · CIK 0001569866 · 10% owner GEYGAN JAMES · CIK 0001734726 · Director and Officer of GVIC GEYGAN JEFFREY RICHART · CIK 0001733547 · Director of GVIC Wilke Stacy · CIK 0001865363 · Officer of GVIC Geygan Kathleen · CIK 0001865425 · Director of GVIC Rice Shawn G · CIK 0002007274 · Director of GVIC Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes. Disclosed balance after: 3,042,066 F4 · price: The reported price represents a weighted average purchase price. The Reporting Person undertakes to provide to the staff, the issuer, or a security holder full information regarding the number of shares purchased at each separate price. F2 · ownership.nature: In addition to Global Value Investment Corp, a Delaware corporation ("GVIC"), this Form 4 is being filed jointly by Jeffrey R. Geygan, a citizen of the United States of America, James P. Geygan, a citizen of the United States of America, Stacy A. Wilke, a citizen of the United States of America, Kathleen M. Geygan, a citizen of the United States of America, and Shawn G. Rice, a citizen of the United States of America, each of whom has the same business address as GVIC. GVIC beneficially owns the shares of common stock, par value $0.0005 per share ("Common Stock"), of Fluent, Inc. reported on this Form 4. F3 · ownership.nature: In accordance with Instruction 4(b)(iv), the entire amount of Common Stock held by GVIC is reported herein. Common Stock reported as indirectly owned by GVIC includes shares owned by Jeffrey R. Geygan, James P. Geygan, Stacy A. Wilke, Kathleen M. Geygan, and Shawn G. Rice. Read SEC document |
| December 03, 2024 Filed Dec 6, 2024 21:30 UTC |
GLOBAL VALUE INVESTMENT CORP.10% owner
GEYGAN JAMESDirector and Officer of GVIC
GEYGAN JEFFREY RICHARTDirector of GVIC
Wilke StacyOfficer of GVIC
Geygan KathleenDirector of GVIC
Rice Shawn GDirector of GVIC
|
OtherCommon Stock | 1,518 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-134141 · ownership.xml · nonDerivative · entry 1 GLOBAL VALUE INVESTMENT CORP. · CIK 0001569866 · 10% owner GEYGAN JAMES · CIK 0001734726 · Director and Officer of GVIC GEYGAN JEFFREY RICHART · CIK 0001733547 · Director of GVIC Wilke Stacy · CIK 0001865363 · Officer of GVIC Geygan Kathleen · CIK 0001865425 · Director of GVIC Rice Shawn G · CIK 0002007274 · Director of GVIC Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes. Disclosed balance after: 3,037,021 F1 · price: As of December 3, 2024, certain separately managed accounts terminated their relationship with, and are no longer advised by, GVIC. The positions held in such accounts are therefore no longer included herein. F2 · ownership.nature: In addition to Global Value Investment Corp, a Delaware corporation ("GVIC"), this Form 4 is being filed jointly by Jeffrey R. Geygan, a citizen of the United States of America, James P. Geygan, a citizen of the United States of America, Stacy A. Wilke, a citizen of the United States of America, Kathleen M. Geygan, a citizen of the United States of America, and Shawn G. Rice, a citizen of the United States of America, each of whom has the same business address as GVIC. GVIC beneficially owns the shares of common stock, par value $0.0005 per share ("Common Stock"), of Fluent, Inc. reported on this Form 4. F3 · ownership.nature: In accordance with Instruction 4(b)(iv), the entire amount of Common Stock held by GVIC is reported herein. Common Stock reported as indirectly owned by GVIC includes shares owned by Jeffrey R. Geygan, James P. Geygan, Stacy A. Wilke, Kathleen M. Geygan, and Shawn G. Rice. Read SEC document |
| December 02, 2024 Filed Dec 4, 2024 19:43 UTC |
FROST PHILLIP MD ET AL10% owner
Frost Gamma Investments Trust10% owner
|
PurchasePre-Funded Warrant · Derivative | 647,892 | $2.31 Strike: $0.00 | $1,499,675.61 |
DisclosureSEC source: 0001437749-24-036682 · rdgdoc.xml · derivative · entry 1 FROST PHILLIP MD ET AL · CIK 0000898860 · 10% owner Frost Gamma Investments Trust · CIK 0001380896 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Frost Gamma Investments Trust Disclosed balance after: 647,892 Underlying: Common Stock · 647,892 shares Expires not disclosed F1 · derivative.expiration_date: The Pre-Funded Warrants will terminate when exercised in full. F2 · ownership.nature: These securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole stockholder of Frost-Nevada Corporation. The reporting persons disclaim beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that any reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| December 02, 2024 Filed Dec 4, 2024 19:37 UTC |
Conlin MatthewDirector · Chief Customer Officer · 10% owner
|
PurchasePre-Funded Warrant · Derivative | 86,385 | $2.31 Strike: $0.00 | $199,955.36 |
DisclosureSEC source: 0001437749-24-036680 · rdgdoc.xml · derivative · entry 2 Conlin Matthew · CIK 0001660879 · Director · Chief Customer Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Conlin Family Foundation Trust Disclosed balance after: 86,385 Underlying: Common Stock · 86,385 shares Expires not disclosed F1 · derivative.exercise_date: The Pre-Funded Warrants will be immediately exercisable after stockholder approval of the offering of the Issuer's Pre-Funded Warrants. F2 · derivative.expiration_date: The Pre-Funded Warrants will terminate when exercised in full. F3 · ownership.nature: The Reporting Person is the Co-Trustee of the Conlin Family Foundation Trust and in such capacity has the shared right to vote and dispose of the securities held by such trust. Read SEC document |
| December 02, 2024 Filed Dec 4, 2024 19:37 UTC |
Conlin MatthewDirector · Chief Customer Officer · 10% owner
|
PurchasePre-Funded Warrant · Derivative | 172,771 | $2.31 Strike: $0.00 | $399,913.03 |
DisclosureSEC source: 0001437749-24-036680 · rdgdoc.xml · derivative · entry 1 Conlin Matthew · CIK 0001660879 · Director · Chief Customer Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 172,771 Underlying: Common Stock · 172,771 shares Expires not disclosed F1 · derivative.exercise_date: The Pre-Funded Warrants will be immediately exercisable after stockholder approval of the offering of the Issuer's Pre-Funded Warrants. F2 · derivative.expiration_date: The Pre-Funded Warrants will terminate when exercised in full. Read SEC document |
| December 02, 2024 Filed Dec 4, 2024 19:35 UTC |
Patrick Donald HuntleyChief Executive Officer
|
PurchasePre-Funded Warrant · Derivative | 21,596 | $2.31 Strike: $0.00 | $49,988.26 |
DisclosureSEC source: 0001437749-24-036678 · rdgdoc.xml · derivative · entry 1 Patrick Donald Huntley · CIK 0001735387 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,596 Underlying: Common Stock · 21,596 shares Expires not disclosed F1 · derivative.exercise_date: The Pre-Funded will be immediately exercisable after stockholder approval of the offering of the Issuer's Pre-Funded Warrants. F2 · derivative.expiration_date: The Pre-Funded Warrants will terminate when exercised in full. Read SEC document |
| December 02, 2024 Filed Dec 4, 2024 19:33 UTC |
Schulke RyanDirector · Chief Strategy Officer · 10% owner
|
PurchasePre-Funded Warrant · Derivative | 259,156 | $2.31 Strike: $0.00 | $599,868.39 |
DisclosureSEC source: 0001437749-24-036676 · rdgdoc.xml · derivative · entry 1 Schulke Ryan · CIK 0001660850 · Director · Chief Strategy Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · The Schulke Inn Family Foundation Trust Disclosed balance after: 259,156 Underlying: Common Stock · 259,156 shares Expires not disclosed F1 · derivative.exercise_date: The Pre-Funded Warrants will be exercisable after stockholder approval of the offering of the Issuer's Pre-Funded Warrants. F2 · derivative.expiration_date: The Pre-Funded Warrants will terminate when exercised in full. F3 · ownership.nature: The Reporting Person is the Co-Trustee of The Schulke Inn Family Foundation Trust and in such capacity has the shared right to vote and dispose of the securities held by such trust. Read SEC document |
| December 02, 2024 Filed Dec 6, 2024 17:10 UTC Amendment |
FROST PHILLIP MD ET AL10% owner
Frost Gamma Investments Trust10% owner
|
GrantPre-Funded Warrant · Derivative | 647,892 | $2.31 Strike: $0.00 | $1,499,675.61 |
DisclosureSEC source: 0001437749-24-036842 · rdgdoc.xml · derivative · entry 1 FROST PHILLIP MD ET AL · CIK 0000898860 · 10% owner Frost Gamma Investments Trust · CIK 0001380896 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Frost Gamma Investments Trust Disclosed balance after: 647,892 Underlying: Common Stock · 647,892 shares Expires not disclosed F1 · kind: On December 4, 2024, the reporting person filed a Form 4 which inadvertently reported the transaction code as "P." The transaction code should have been reported as "A" for a grant, award or other acquisition pursuant to Rule 16b-3(d). F2 · derivative.expiration_date: The Pre-Funded Warrants will terminate when exercised in full. F3 · ownership.nature: These securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole stockholder of Frost-Nevada Corporation. The reporting persons disclaim beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that any reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| December 02, 2024 Filed Dec 6, 2024 17:13 UTC Amendment |
Conlin MatthewDirector · Chief Customer Officer · 10% owner
|
GrantPre-Funded Warrant · Derivative | 86,385 | $2.31 Strike: $0.00 | $199,955.36 |
DisclosureSEC source: 0001437749-24-036845 · rdgdoc.xml · derivative · entry 2 Conlin Matthew · CIK 0001660879 · Director · Chief Customer Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Conlin Family Foundation Trust Disclosed balance after: 86,385 Underlying: Common Stock · 86,385 shares Expires not disclosed F1 · kind: On December 4, 2024, the reporting person filed a Form 4 which inadvertently reported the transaction code as "P." The transaction code should have been reported as "A" for a grant, award or other acquisition pursuant to Rule 16b-3(d). F2 · derivative.exercise_date: The Pre-Funded Warrants will be immediately exercisable after stockholder approval of the offering of the Issuer's Pre-Funded Warrants. F3 · derivative.expiration_date: The Pre-Funded Warrants will terminate when exercised in full. F4 · ownership.nature: The Reporting Person is the Co-Trustee of the Conlin Family Foundation Trust and in such capacity has the shared right to vote and dispose of the securities held by such trust. Read SEC document |
| December 02, 2024 Filed Dec 6, 2024 17:13 UTC Amendment |
Conlin MatthewDirector · Chief Customer Officer · 10% owner
|
GrantPre-Funded Warrant · Derivative | 172,771 | $2.31 Strike: $0.00 | $399,913.03 |
DisclosureSEC source: 0001437749-24-036845 · rdgdoc.xml · derivative · entry 1 Conlin Matthew · CIK 0001660879 · Director · Chief Customer Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 172,771 Underlying: Common Stock · 172,771 shares Expires not disclosed F1 · kind: On December 4, 2024, the reporting person filed a Form 4 which inadvertently reported the transaction code as "P." The transaction code should have been reported as "A" for a grant, award or other acquisition pursuant to Rule 16b-3(d). F2 · derivative.exercise_date: The Pre-Funded Warrants will be immediately exercisable after stockholder approval of the offering of the Issuer's Pre-Funded Warrants. F3 · derivative.expiration_date: The Pre-Funded Warrants will terminate when exercised in full. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.